Long COVID patients with abnormal cardiopulmonary PET/MR findings may be more likely to develop heart and lung diseases, according to new research published in the July issue of The Journal of Nuclear Medicine. The study—which included the largest cohort of long COVID subjects with cardiopulmonary symptoms with the longest follow-up duration—suggests that abnormal cardiopulmonary PET/MR should be considered a risk factor for future cardiac and pulmonary disease and that closer monitoring is warranted in these patients.

With a new method, researchers have captured a high-resolution metabolic “map” of how cells orchestrate glucose processing, revealing a hidden world where organelles and molecular complexes collaborate when responding to a rush of nutrients. The results of the pioneering work provide insights into an organizational and molecular framework that can be used to study how metabolic processes are disrupted in diseases and aging.